The Agency for Care Effectiveness (ACE) is the national health technology assessment (HTA) agency in Singapore. ACE reviews clinical and economic evidence to determine how well health technologies (such as drugs, vaccines and medical devices) work in relation to how much they cost. This information is then used by MOH to make subsidy recommendations for the public hospitals. In 2021, the Consumer Engagement and Education (CEE) team was set up to help patients, carers and the public become involved in ACE’s work. Moving forward, CEE will be inviting patient and/or volunteer organisations to provide inputs into ACE’s HTA projects to ensure that any subsidy recommendations are relevant to the people who are affected by them. Whether you use healthcare services or represent those who do, we welcome you to join us to find out how you can get involved.

The Centre of Regulatory Excellence  (CoRE) and ACE will co-host a special dialogue for members of patient and volunteer organisations in Singapore with an interest in contributing to HTA.